Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis

Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C (1999)
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96(16): 9409-9414.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ;
Abstract / Bemerkung
One mechanism leading to neurodegeneration during Alzheimer's disease (AD) is amyloid beta peptide (A beta) neurotoxicity. A beta elicits in cultured central nervous system neurons a biphasic response: a low-dose neurotrophic response and a high-dose neurotoxic response. Previously me reported that NF-kappa B is activated by low doses of A beta only. Here we show that NF-kappa B activation leads to neuroprotection. In primary neurons me found that a pretreatment with 0.1 mu M A beta-(1-40) protects against neuronal death induced with 10 mu M A beta-(1-40). As a known neuroprotective agent we nest analyzed the effect of tumor necrosis factor alpha (TNF-alpha). Maximal activation of NF-kappa B was found with 2 ng/ml TNF-alpha. Pretreatment with TNF-alpha protected cerebellar granule cells from tell death induced by 10 mu M A beta-(1-40). This protection is described by an inverted U-shaped dose response and is maximal with a NF-kappa B-activating dose. The molecular specificity of this protective effect was analyzed by specific blockade of NF-kappa B activation. Overexpression of a transdominant negative I kappa B-alpha blocks NF-kappa B activation and potentiates A beta-mediated neuronal apoptosis. Our findings show that activation of NF-kappa B is the underlying mechanism of the neuroprotective effect of low-dose A beta and TNF-alpha. In accordance with these in vitro data we find that nuclear NF-kappa B immunoreactivity around various plaque stages of AD patients is reduced in comparison to age-matched controls, Taken together these data suggest that pharmacological NF-kappa B activation may be a useful approach in the treatment of AD and related neurodegenerative disorders.
Erscheinungsjahr
Zeitschriftentitel
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Band
96
Zeitschriftennummer
16
Seite
9409-9414
ISSN
eISSN
PUB-ID

Zitieren

Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C. Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1999;96(16):9409-9414.
Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B., & Kaltschmidt, C. (1999). Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 96(16), 9409-9414. doi:10.1073/pnas.96.16.9409
Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B., and Kaltschmidt, C. (1999). Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96, 9409-9414.
Kaltschmidt, B., et al., 1999. Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 96(16), p 9409-9414.
B. Kaltschmidt, et al., “Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis”, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 96, 1999, pp. 9409-9414.
Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B., Kaltschmidt, C.: Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 96, 9409-9414 (1999).
Kaltschmidt, Barbara, Uherek, M., Wellmann, H., Volk, B., and Kaltschmidt, Christian. “Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis”. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96.16 (1999): 9409-9414.

157 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Preconditioning-induced neuroprotection is mediated by reactive oxygen species.
Ravati A, Ahlemeyer B, Becker A, Krieglstein J., Brain Res 866(1-2), 2000
PMID: 10825477
Microglia and neurodegeneration.
Rozemuller JM, van Muiswinkel FL., Eur J Clin Invest 30(6), 2000
PMID: 10849012
Silencing survival data.
Mattson MP, Barger SW, Dantzer R., Trends Neurosci 23(10), 2000
PMID: 11203139
Control of apoptosis by Rel/NF-kappaB transcription factors.
Barkett M, Gilmore TD., Oncogene 18(49), 1999
PMID: 10602466

62 References

Daten bereitgestellt von Europe PubMed Central.

Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ.
Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM., Acta Neuropathol. 89(1), 1995
PMID: 7709729
Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease.
Sheng JG, Zhou XQ, Mrak RE, Griffin WS., J. Neuropathol. Exp. Neurol. 57(7), 1998
PMID: 9690675
Inhibition of TNF-induced apoptosis by NF-kappa B.
Van Antwerp DJ, Martin SJ, Verma IM, Green DR., Trends Cell Biol. 8(3), 1998
PMID: 9695819
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH., Am. J. Pathol. 132(1), 1988
PMID: 2456021
Ultrastructural studies of the cells forming amyloid fibers in classical plaques.
Wisniewski HM, Wegiel J, Wang KC, Kujawa M, Lach B., Can J Neurol Sci 16(4 Suppl), 1989
PMID: 2553231
Microglia in cerebellar plaques in Alzheimer's disease.
Mattiace LA, Davies P, Yen SH, Dickson DW., Acta Neuropathol. 80(5), 1990
PMID: 2251906
Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease.
Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C., Glia 7(1), 1993
PMID: 8423065
Activation of microglial cells by beta-amyloid protein and interferon-gamma.
Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F., Nature 374(6523), 1995
PMID: 7715705
Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression.
Togashi H, Sasaki M, Frohman E, Taira E, Ratan RR, Dawson TM, Dawson VL., Proc. Natl. Acad. Sci. U.S.A. 94(6), 1997
PMID: 9122255

AUTHOR UNKNOWN, 0

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 10430956
PubMed | Europe PMC

Suchen in

Google Scholar